Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation
- PMID:22171309
- PMCID: PMC3217704
- DOI: 10.4103/2231-4040.85524
Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation
Abstract
Transdermal administration of drugs is generally limited by the barrier function of the skin. Vesicular systems are one of the most controversial methods for transdermal delivery of active substances. The interest in designing transdermal delivery systems was relaunched after the discovery of elastic vesicles like transferosomes, ethosomes, cubosomes, phytosomes, etc. This paper presents the composition, mechanisms of penetration, manufacturing and characterization methods of transferosomes as transdermal delivery systems of active substances. For a drug to be absorbed and distributed into organs and tissues and eliminated from the body, it must pass through one or more biological membranes/barriers at various locations. Such a movement of drug across the membrane is called as drug transport. For the drugs to be delivered to the body, they should cross the membranous barrier. The concept of these delivery systems was designed in an attempt to concentrate the drug in the tissues of interest, while reducing the amount of drug in the remaining tissues. Hence, surrounding tissues are not affected by the drug. In addition, loss of drug does not happen due to localization of drug, leading to get maximum efficacy of the medication. Therefore, the phospholipid based carrier systems are of considerable interest in this era.
Keywords: Lecithin; stratum corneum; surfactant; transferosomes; vesicles.
Conflict of interest statement
Similar articles
- A comprehensive review on transethosomes as a novel vesicular approach for drug delivery through transdermal route.Munir M, Zaman M, Waqar MA, Hameed H, Riaz T.Munir M, et al.J Liposome Res. 2024 Mar;34(1):203-218. doi: 10.1080/08982104.2023.2221354. Epub 2023 Jun 20.J Liposome Res. 2024.PMID:37338000Review.
- Therapeutic and cosmeceutical potential of ethosomes: An overview.Verma P, Pathak K.Verma P, et al.J Adv Pharm Technol Res. 2010 Jul;1(3):274-82. doi: 10.4103/0110-5558.72415.J Adv Pharm Technol Res. 2010.PMID:22247858Free PMC article.
- Biomimetic Lipid-Based Nanosystems for Enhanced Dermal Delivery of Drugs and Bioactive Agents.Kotla NG, Chandrasekar B, Rooney P, Sivaraman G, Larrañaga A, Krishna KV, Pandit A, Rochev Y.Kotla NG, et al.ACS Biomater Sci Eng. 2017 Jul 10;3(7):1262-1272. doi: 10.1021/acsbiomaterials.6b00681. Epub 2017 Feb 16.ACS Biomater Sci Eng. 2017.PMID:33440514
- Phytochemical Delivery Through Transferosome (Phytosome): An Advanced Transdermal Drug Delivery for Complementary Medicines.Chen RP, Chavda VP, Patel AB, Chen ZS.Chen RP, et al.Front Pharmacol. 2022 Feb 23;13:850862. doi: 10.3389/fphar.2022.850862. eCollection 2022.Front Pharmacol. 2022.PMID:35281927Free PMC article.Review.
- Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments.Matharoo N, Mohd H, Michniak-Kohn B.Matharoo N, et al.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jan-Feb;16(1):e1918. doi: 10.1002/wnan.1918. Epub 2023 Aug 1.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024.PMID:37527953Review.
Cited by
- Deformable Nanovesicle-Loaded Gel for Buccal Insulin Delivery.Guo Y, Yang Y, Xu Y, Meng Y, Ye J, Xia X, Liu Y.Guo Y, et al.Pharmaceutics. 2022 Oct 22;14(11):2262. doi: 10.3390/pharmaceutics14112262.Pharmaceutics. 2022.PMID:36365081Free PMC article.
- Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.Witika BA, Bassey KE, Demana PH, Siwe-Noundou X, Poka MS.Witika BA, et al.Int J Mol Sci. 2022 Aug 26;23(17):9668. doi: 10.3390/ijms23179668.Int J Mol Sci. 2022.PMID:36077066Free PMC article.Review.
- Transdermal Glipizide Delivery System Based on Chitosan-Coated Deformable Liposomes: Development, Ex Vivo, and In Vivo Studies.Badran MM, Alouny NN, Aldosari BN, Alhusaini AM, Abou El Ela AES.Badran MM, et al.Pharmaceutics. 2022 Apr 10;14(4):826. doi: 10.3390/pharmaceutics14040826.Pharmaceutics. 2022.PMID:35456660Free PMC article.
- DOE-Assisted Formulation, Optimization, and Characterization of Tioconazole-Loaded Transferosomal Hydrogel for the Effective Treatment of Atopic Dermatitis: In Vitro and In Vivo Evaluation.Kharwade R, Ali N, Gangane P, Pawar K, More S, Iqbal M, Bhat AR, AlAsmari AF, Kaleem M.Kharwade R, et al.Gels. 2023 Apr 4;9(4):303. doi: 10.3390/gels9040303.Gels. 2023.PMID:37102915Free PMC article.
- Drug delivery strategies for chemoprevention of UVB-induced skin cancer: A review.Bagde A, Mondal A, Singh M.Bagde A, et al.Photodermatol Photoimmunol Photomed. 2018 Jan;34(1):60-68. doi: 10.1111/phpp.12368.Photodermatol Photoimmunol Photomed. 2018.PMID:29150967Free PMC article.Review.
References
- Vyas SP, Khar RK. 1st Ed. Delhi: CBS Publishers; 2002. Targeted and controlled drug delivery; pp. 219–43.
- Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Indian J Pharm Sci. 2004;66:72–81.
- Kumar R, Philip A. Modified Transdermal Technologies: Breaking the barriers of drug permeation via skin. Trop J Pharm Res. 2007;6:633–44.
- Chien YW. Logics of transdermal controlled drug administration. Drug Dev Ind Pharm. 1983;9:497–520.
- Nandha A, Nandha S, Dhall M, Rao R. Transferosomes: A novel Ultra deformable vesicular carrier for transdermal drug delivery. Pharma Info Net. 2005 Oct;:395.
Related information
LinkOut - more resources
Full Text Sources